Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: GlobalData
$250.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arkema SA Confirms FY 2012 EBITDA Guidance


Tuesday, 18 Sep 2012 01:30am EDT 

Arkema SA announced that it confirms to register EBITDA of close to EUR 1 billion for full year 2012. It also announced that its target for 2016 is to reach EBITDA of EUR 1,250 million and revenue of EUR 8 billion. 

Latest Key Developments in Chemicals

Company Quote

69.07
0.18 +0.26%
14 Jul 2014